PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

UK: Time for a Rethink on Managed Access Spend

The Answer is Video. Now What Was the Question?

Industry Seeks Speedy Congressional Approval of New User Fee Plan

Advertisement
Top Story
Pharma Olympics: Who's On the Podium?
In the spirit of the Olympics, Casey McDonald cites some of the feel-good and not-so-good stories making waves in the competitive world of pharma
... /Read more/
Advertisement
Breaking the Circle of Distrust with a Radical PLC Pricing Model
On Demand
Learn more
Legal
Cuozzo vs Lee: How Many Bites of the Apple Are Enough?
Having lobbied hard to have Inter Partes Review proceedings (IPRs) enacted, the tech industry may now be regretting what it wished for, write Traci Medford-Rosow and Peter C. Richardson
... /Read more/
Advertisement
Best Practices for Integrating Biomarkers across the Drug Development Continuum
On Demand
Learn more
Regulatory
Drug Shortages Raise Economic and Ethical Challenges
Despite some success in reducing supply disruptions in the US and abroad, analysts are looking more closely at market-based strategies to encourage more diverse production, writes Jill Wechsler
... /Read more/
Special Feature
Pharm Exec's 15th Annual Industry Audit
Our latest industry review of shareholder value reveals a sharp performance differential between companies with specialized therapeutic focus and those relying on line diversity, size and scale. By Bill Trombetta
... /Read more/
ADVERTISEMENT
Calendar
/ September 15–16: Compliance Congress for Specialty Products /
Boston, MA
/ October 5: Drug, Chemical & Associated Technology Association (DCAT) After the Show /
Barcelona, Spain
/ October 27–28: MedComm 2016 /
San Francisco, CA
/ December 13–14: Life Sciences Trade and Channel Strategies /
Philadelphia, PA
/ February 22–23, 2017: Speaker Programs 2017 /
Philadelphia, PA
 
 
Industry update
//Valeant Pharmaceuticals (Laval, Quebec) named Christina Ackermann as Executive Vice President and General Counsel and Scott Hirsch as Senior Vice President, Business Strategy and Communications.//Inspyr Therapeutics, Inc. (San Antonio, TX) appointed Christopher Lowe as President and Chief Executive Officer.//Biotica Pharmaceuticals Inc. (St. Petersburg, FL) elected Abbott and Bayer veteran Dr. P.C. Sundareswaran as its President & CEO.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com